RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 127 filers reported holding RHYTHM PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 2.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5 | +25.0% | 227 | 0.0% | 0.00% | – |
| Q2 2023 | $4 | 0.0% | 227 | 0.0% | 0.00% | – |
| Q1 2023 | $4 | -42.9% | 227 | 0.0% | 0.00% | – |
| Q4 2022 | $7 | -99.8% | 227 | +32.0% | 0.00% | – |
| Q3 2022 | $4,000 | +300.0% | 172 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | -50.0% | 172 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | 0.0% | 172 | 0.0% | 0.00% | – |
| Q4 2021 | $2,000 | 0.0% | 172 | 0.0% | 0.00% | – |
| Q3 2021 | $2,000 | 0.0% | 172 | +75.5% | 0.00% | – |
| Q2 2021 | $2,000 | 0.0% | 98 | 0.0% | 0.00% | – |
| Q1 2021 | $2,000 | 0.0% | 98 | +18.1% | 0.00% | – |
| Q4 2020 | $2,000 | -60.0% | 83 | -66.5% | 0.00% | – |
| Q3 2020 | $5,000 | +25.0% | 248 | 0.0% | 0.00% | – |
| Q2 2020 | $4,000 | 0.0% | 248 | 0.0% | 0.00% | – |
| Q1 2020 | $4,000 | -33.3% | 248 | 0.0% | 0.00% | – |
| Q4 2019 | $6,000 | +20.0% | 248 | +13.2% | 0.00% | – |
| Q3 2019 | $5,000 | 0.0% | 219 | 0.0% | 0.00% | – |
| Q2 2019 | $5,000 | -16.7% | 219 | 0.0% | 0.00% | – |
| Q1 2019 | $6,000 | -25.0% | 219 | -27.0% | 0.00% | – |
| Q4 2018 | $8,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 4,909,956 | $142,977,919 | 8.04% |
| Opaleye Management Inc. | 735,000 | $21,403,200 | 7.44% |
| Frazier Life Sciences Management, L.P. | 1,894,000 | $55,153,280 | 3.43% |
| RA Capital Management | 5,516,067 | $160,627,871 | 3.26% |
| Altium Capital Management LP | 170,000 | $4,950,400 | 2.52% |
| Samsara BioCapital, LLC | 345,293 | $10,054,932 | 2.16% |
| Rock Springs Capital Management LP | 1,760,865 | $51,276,389 | 1.23% |
| Parkman Healthcare Partners LLC | 157,862 | $4,596,941 | 1.22% |
| Baker Brothers Advisors | 6,354,608 | $185,046,185 | 1.11% |
| EAM Investors, LLC | 164,695 | $4,795,918 | 0.99% |